173 related articles for article (PubMed ID: 36380418)
1. Glucose and mannose analogs inhibit KSHV replication by blocking N-glycosylation and inducing the unfolded protein response.
Schlesinger M; McDonald C; Ahuja A; Alvarez Canete CA; Nuñez Del Prado Z; Naipauer J; Lampidis T; Mesri EA
J Med Virol; 2023 Jan; 95(1):e28314. PubMed ID: 36380418
[TBL] [Abstract][Full Text] [Related]
2. Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.
Leung HJ; Duran EM; Kurtoglu M; Andreansky S; Lampidis TJ; Mesri EA
Antimicrob Agents Chemother; 2012 Nov; 56(11):5794-803. PubMed ID: 22926574
[TBL] [Abstract][Full Text] [Related]
3. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
4. KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication.
Johnston BP; Pringle ES; McCormick C
PLoS Pathog; 2019 Dec; 15(12):e1008185. PubMed ID: 31790507
[TBL] [Abstract][Full Text] [Related]
5. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
7. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
[TBL] [Abstract][Full Text] [Related]
9. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
11. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus.
Zhu W; Burnette A; Dorjsuren D; Roberts PE; Huleihel M; Shoemaker RH; Marquez VE; Agbaria R; Sei S
Antimicrob Agents Chemother; 2005 Dec; 49(12):4965-73. PubMed ID: 16304159
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis.
Chen J; Zhang H; Chen X
Antiviral Res; 2020 Aug; 180():104825. PubMed ID: 32461120
[TBL] [Abstract][Full Text] [Related]
14. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
15. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
16. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
[TBL] [Abstract][Full Text] [Related]
17. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication.
Uppal T; Meyer D; Agarwal A; Verma SC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728255
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function.
Yang WS; Lin TY; Chang L; Yeh WW; Huang SC; Chen TY; Hsieh YT; Chen ST; Li WC; Pan CC; Campbell M; Yen CH; Chen YA; Chang PC
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723026
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
20. Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II.
Xu B; Wang L; González-Molleda L; Wang Y; Xu J; Yuan Y
Antimicrob Agents Chemother; 2014; 58(1):563-73. PubMed ID: 24295975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]